Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Findsnews2022-03-30T21:12:29+00:00March 30th, 2022|The New York Times|
Companies Finalize $26 Billion Deal With States and Cities to End Opioid Lawsuitsnews2022-02-25T14:12:55+00:00February 25th, 2022|The New York Times|
¿Vacunar a los niños pequeños o esperar?news2022-02-11T18:08:17+00:00February 11th, 2022|The New York Times|
C.D.C. Proposes New Guidelines for Treating Pain, Including Opioid Usenews2022-02-10T13:55:27+00:00February 10th, 2022|The New York Times|
The Next Vaccine Debate: Immunize Young Children Now, or Wait?news2022-02-09T20:16:21+00:00February 9th, 2022|The New York Times|
Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decisionnews2021-12-31T21:39:22+00:00December 31st, 2021|The New York Times|
F.D.A. Clears Pfizer’s Covid Pill for High-Risk Patients 12 and Oldernews2021-12-22T22:02:31+00:00December 22nd, 2021|The New York Times|
Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstaclesnews2021-12-21T02:08:14+00:00December 21st, 2021|The New York Times|
Pfizer’s Covid Pill Works Well, Company Confirms in Final Analysisnews2021-12-15T02:22:07+00:00December 15th, 2021|The New York Times|
Merck’s Covid Pill Might Pose Risks for Pregnant Womennews2021-12-13T15:27:03+00:00December 13th, 2021|The New York Times|
